Longevity & Anti-Aging – Eric Marcotulli, CEO, Elysium Health

The Bob Johnston Podcast

Hi Gang, we’re kicking off the Fall podcast season with a deep dive discussion around longevity and anti-aging with Elysium Health’s Co-founder and CEO, Eric Marcotulli.

I interviewed Eric at the Executive Council’s annual Health & Biotech Summit in 2017, which feels like forever ago, particularly given all of the buzz around anti-aging regimens and the popularization of the space from various industry leaders and mainstream press.

To start off, Eric and I discuss why it’s important to track aging. This might seem like a basic questions but the idea of “aging” isn’t so much about “old age” as it is about addressing health in a more holistic manner, as you’ll learn. Chronological age is only a number, in a sense, and what might matter most is cellular age. More on that in our discussion.

We also talk about quantifying and measuring products such as Elysium’s Basis, which is Eric’s core product. Elysium also has a product called Index which measures your biological age and also tracks your cumulative rate of aging which may be the most important metric of all. Absorption rate of products like Basis is also an important factor and we hit on that, as well.

On the personal front, we touch on Eric’s evolving daily regimen vis a vis supplements and routines (AM/PM, exercise, diet, etc.). It’s always fun to discuss this particular topic with guests because I personally get tips that I can use and of course you can hopefully gain some actionable tips, too.

Finally, we talk about what’s coming down the pipeline for Elysium and across the industry and what Eric is most excited about.

Eric Marcotulli, Elysium Health co-founder and chief executive officer, graduated from Harvard Business School and joined Sequoia Capital as its youngest partner to lead growth investing in mobile technologies. While in Silicon Valley, Marcotulli realized that despite the significant, positive impact of new technologies on our understanding of health and disease,

there remained a lack of innovation in the consumer-facing portion of the healthcare market beyond wearables and basic mobile apps.

With a keen interest in aging research and its potential to have a profound impact on the most important areas of health, he wanted to create a company focused on developing compelling compounds found in nature that support long-term health.